J&J offers few details on headcount, HQ following $16.6B Abiomed acquisition

Johnson & Johnson Inc. is offering few details yet about the future of Abiomed’s Massachusetts footprint once its acquisition of the medical device maker closes in early 2023. Here’s what we know.